2026-01-13 - Analysis Report
**Company Overview**
Chainlink is a decentralised oracle network that provides real-world data to smart contracts.

**Simple Numbers**

* Cumulative return of review stock: 516.30%
* Cumulative return of comparison stock (S&P 500, VOO): 75.93%
* Divergence: 440.40
* Relative divergence: 11.10%
* CAGR (2018-2020): 1519.0%
* CAGR (2019-2021): 1800.0%
* CAGR (2020-2022): 218.0%
* CAGR (2021-2023): -1225.0%
* CAGR (2022-2024): -381.0%
* CAGR (2023-2025): -360.0%
* MDD (2018-2020): 67.9%
* MDD (2019-2021): 65.1%
* MDD (2020-2022): 74.9%
* MDD (2021-2023): 78.3%
* MDD (2022-2024): 63.2%
* MDD (2023-2025): 74.4%
* Alpha (2018-2020): 1498.0%
* Alpha (2019-2021): 1757.0%
* Alpha (2020-2022): 219.0%
* Alpha (2021-2023): -1226.0%
* Alpha (2022-2024): -401.0%
* Alpha (2023-2025): -422.0%
* Beta (2018-2020): 7.9B
* Beta (2019-2021): 13.7B
* Beta (2020-2022): 3.9B
* Beta (2021-2023): 10.4B
* Beta (2022-2024): 14.0B
* Beta (2023-2025): 8.5B
* Close: $13.20
* 5-day SMA: $13.22
* 20-day SMA: $12.84
* 60-day SMA: $13.13
* Market Risk Indicator (MRI): 0.70
* RSI: 60.64
* PPO: 0.58
* Expected Return: 9530.20%

**Simple Analysis**

* The cumulative return of the review stock is significantly higher than the comparison stock (S&P 500, VOO).
* The divergence is 440.40, indicating a significant difference in cumulative return.
* The relative divergence of 11.10% indicates that the review stock is currently at the top 11.10% percentile of past data.
* The CAGR and Alpha values for the review stock are highly volatile, indicating significant growth and decline.
* The MDD values for the review stock are relatively high, indicating significant drawdowns.
* The Beta values for the review stock are highly volatile, indicating significant market exposure.
* The Market Risk Indicator (MRI) of 0.70 indicates a medium investment risk.
* The RSI of 60.64 indicates that the review stock is currently overbought.
* The PPO of 0.58 indicates that the review stock is currently in a sell signal.
* The Expected Return of 9530.20% is a highly optimistic forecast, indicating a potential for significant gains.

**Recent Stock Price Fluctuations**

* The review stock price has dropped 8.4% in the last 5 days.
* The 5-day SMA is trading above the 20-day SMA, indicating a short-term uptrend.
* The 60-day SMA is trading above the 5-day SMA, indicating a medium-term downtrend.

**RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence**

* The RSI of 60.64 indicates that the review stock is currently overbought.
* The PPO of 0.58 indicates that the review stock is currently in a sell signal.
* The Delta_Previous_Relative_Divergence of -0.90 indicates that the review stock's relative divergence is worsening.
* The Expected Return of 9530.20% is a highly optimistic forecast, indicating a potential for significant gains.

**Recent News & Significant Events**

* Chainlink (LINK) Price Today: LINK Live Price, Charts, News - Crypto.com (news.google.com)
* Chainlink's LINK Drops 8% Below Support Despite Largest Token Buyback Since August - Yahoo! Finance Canada (news.google.com)
* ChainLink USD: Key Recent Developments Demonstrating Growth - Seeking Alpha (news.google.com)
* Strategy Announces Establishment of $1.44 Billion USD Reserve and Updates FY 2025 Guidance - Strategy (news.google.com)
* Chainlink's LINK Tumbles 4% as Selling Pressure Mounts - Yahoo Finance UK (news.google.com)
* CaliberCos Shares Skyrocket on Chainlink Purchase - marketscreener.com (news.google.com)

**Analyst Opinions**

Analyst Consensus:

**Comprehensive Analysis (Summary of previous items, including news)**

Based on the analysis, the review stock is highly volatile, with a significant divergence in cumulative return from the comparison stock (S&P 500, VOO). The review stock's CAGR and Alpha values are highly volatile, indicating significant growth and decline. The MDD values for the review stock are relatively high, indicating significant drawdowns. The Beta values for the review stock are highly volatile, indicating significant market exposure. The Market Risk Indicator (MRI) of 0.70 indicates a medium investment risk. The RSI and PPO indicators suggest that the review stock is currently overbought and in a sell signal. The Expected Return of 9530.20% is a highly optimistic forecast, indicating a potential for significant gains. However, the recent price fluctuations and news events suggest that the review stock is experiencing selling pressure and may be in a downtrend.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.